β-Amyloid Deposition Monitoring and Control Systems for Industrial and Agricultural Applications

Publication ID: 24-11857568_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “β-Amyloid Deposition Monitoring and Control Systems for Industrial and Agricultural Applications,” Published Technical Disclosure No. 24-11857568_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857568_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,568.

Summary of the Inventive Concept

The present inventive concept relates to novel systems and methods for monitoring and controlling β-amyloid deposition in various industries, leveraging the core technology of the original patent to address unmet needs in water quality, biofilm formation, agricultural soil health, and air quality.

Background and Problem Solved

The original patent disclosed means and methods for treating and preventing Alzheimer's disease, focusing on the role of β-amyloid deposition in dementia. However, β-amyloid deposition is not exclusive to biological systems and can have significant implications in industrial and agricultural contexts. The present inventive concept addresses the limitations of the original patent by applying its core technology to entirely new fields, providing innovative solutions for monitoring and controlling β-amyloid deposition in these industries.

Detailed Description of the Inventive Concept

The newly generated claims describe systems and methods for detecting β-amyloid deposition in water samples, industrial equipment, agricultural soil, and air samples. These systems comprise sensors for detecting β-amyloid deposition and controllers for adjusting treatment parameters or implementing corrective actions. The inventive concept also encompasses methods for reducing biofilm formation, improving crop yields, and enhancing air quality by administering aluminum salts to inhibit β-amyloid deposition. The systems and methods can be integrated into existing industrial and agricultural processes, providing a proactive approach to mitigating the effects of β-amyloid deposition.

Novelty and Inventive Step

The novelty of the present inventive concept lies in its application of β-amyloid deposition monitoring and control to industrial and agricultural contexts, which was not contemplated in the original patent. The inventive step resides in the recognition of the relevance of β-amyloid deposition to these fields and the development of tailored systems and methods to address the specific challenges posed by β-amyloid deposition in these industries.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different sensors or detection methods, variations in the aluminum salt administration protocols, or the integration of machine learning algorithms to optimize system performance. Additionally, the inventive concept could be adapted for use in other industries, such as cosmetics or pharmaceuticals, where β-amyloid deposition may have significant implications.

Potential Commercial Applications and Market

The present inventive concept has significant commercial potential in various industries, including water treatment, industrial equipment manufacturing, agriculture, and air quality management. The market for β-amyloid deposition monitoring and control systems is expected to grow rapidly as industries recognize the importance of addressing this previously overlooked issue. Advantage Therapeutics, Inc. is well-positioned to capitalize on this opportunity, leveraging its expertise in β-amyloid deposition to develop innovative solutions for a broad range of industrial and agricultural applications.

Field of Art

Biomedical engineering and materials science, with expertise in protein deposition, sensor technologies, and industrial/agricultural monitoring systems

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degree in bioengineering or materials science, familiar with protein interaction mechanisms, sensor design, and cross-disciplinary applications of medical research findings

Obviousness Rationale

A PHOSITA would recognize that the core mechanism of β-amyloid detection and aluminum salt intervention disclosed in the source patent could be readily extended to industrial and agricultural monitoring contexts. The fundamental principles of protein deposition inhibition are transferable across different environmental domains. The technical variations represent predictable applications of the original patent's core scientific insights, utilizing standard sensor and control technologies.

Obvious Combinations & Variations

Source Patent Element
Aluminum salt administration for inhibiting β-amyloid deposition in cognitive contexts
PTD Variation
Applying aluminum salt intervention to industrial water quality and agricultural soil health management
Obviousness Reasoning
Known technique of using aluminum salts to interrupt protein aggregation, with predictable results when applied to different environmental systems
Source Patent Element
Detection of β-amyloid levels through diagnostic measurements
PTD Variation
Implementing sensor-based detection systems for β-amyloid in water, soil, and air samples
Obviousness Reasoning
Standard sensor technologies can be adapted to detect protein aggregation across multiple sample types using well-established detection methodologies
Source Patent Element
Medical diagnostic approach of monitoring protein deposition
PTD Variation
Developing industrial and agricultural monitoring systems based on protein aggregation detection
Obviousness Reasoning
Transferring diagnostic principles to industrial monitoring represents a predictable engineering design choice with finite solution set
Source Patent Element
Quantitative assessment of protein deposition impacts
PTD Variation
Creating control systems that adjust treatment parameters based on detected β-amyloid levels
Obviousness Reasoning
Feedback control mechanisms are standard engineering practice when quantitative measurement technologies are available
Source Patent Element
Pharmaceutical intervention targeting protein aggregation
PTD Variation
Developing proactive intervention strategies for biofilm prevention and crop health management
Obviousness Reasoning
Cross-domain application of protein interaction inhibition represents a logical extension of fundamental scientific understanding
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. § 103, the technical variations disclosed herein would have been obvious to a person having ordinary skill in the art at the time of invention, as derived from US Patent 11857568. The present publication demonstrates that the core scientific principles of β-amyloid deposition inhibition are readily adaptable across multiple technical domains through predictable engineering modifications, thereby rendering subsequent claims of novelty non-patentable.

Original Patent Information

Patent NumberUS 11,857,568
TitleTreatment and prevention of Alzheimer's disease (AD)
Assignee(s)Advantage Therapeutics, Inc.